Literature DB >> 21088115

Urokinase receptor mediates mobilization, migration, and differentiation of mesenchymal stem cells.

Krishna C Vallabhaneni1, Sergey Tkachuk, Yulia Kiyan, Nelli Shushakova, Hermann Haller, Inna Dumler, Gabriele Eden.   

Abstract

AIMS: Multipotent mesenchymal stem cells (MSCs) have regenerative properties and are recognized as putative players in the pathogenesis of cardiovascular diseases. The underlying molecular mechanisms remain, however, sparsely explored. Our study was designed to elucidate a probable role for the multifunctional urokinase (uPA)/urokinase receptor (uPAR) system in MSC regulation. Though uPAR has been implicated in a broad spectrum of pathophysiological processes, nothing is known about uPAR in MSCs. METHODS AND
RESULTS: uPAR was required to mobilize MSCs from the bone marrow (BM) of mice stimulated with granulocyte colony-stimulating factor (G-CSF) in vivo. An insignificant amount of MSCs was mobilized in uPAR(-/-) C57BL/6J mice, whereas in wild-type animals G-CSF induced an eight-fold increase of mobilized MSCs. uPAR(-/-) mice revealed up-regulated expression of G-CSF and stromal cell-derived factor 1 (CXCR4) receptors in BM. uPAR down-regulation leads to inhibition of human MSC migration, as shown in different migration assays. uPAR down- or up-regulation resulted in inhibition or stimulation of MSC differentiation into vascular smooth muscle cells (VSMCs) correspondingly, as monitored by changes in cell morphology and expression of specific marker proteins. Injection of fluorescently labelled MSCs in non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice after femoral artery wire injury demonstrated impaired engraftment of uPAR-deficient MSCs at the place of injury.
CONCLUSIONS: These data suggest a multifaceted function of uPAR in MSC biology contributing to vascular repair. uPAR might guide and control the trafficking of MSCs to the vascular wall in response to injury or ischaemia and their differentiation towards functional VSMCs at the site of arterial injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21088115     DOI: 10.1093/cvr/cvq362

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  25 in total

1.  Vascular smooth muscle cells initiate proliferation of mesenchymal stem cells by mitochondrial transfer via tunneling nanotubes.

Authors:  Krishna C Vallabhaneni; Hermann Haller; Inna Dumler
Journal:  Stem Cells Dev       Date:  2012-07-13       Impact factor: 3.272

2.  Easily-handled method to isolate mesenchymal stem cells from coagulated human bone marrow samples.

Authors:  Heng-Xiang Wang; Zhi-Yong Li; Zhi-Kun Guo; Zi-Kuan Guo
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

Review 3.  Role of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression.

Authors:  Beate Heissig; Douaa Dhahri; Salita Eiamboonsert; Yousef Salama; Hiroshi Shimazu; Shinya Munakata; Koichi Hattori
Journal:  Cell Mol Life Sci       Date:  2015-09-09       Impact factor: 9.261

Review 4.  Extracellular vesicles as carriers of microRNA, proteins and lipids in tumor microenvironment.

Authors:  Patrice Penfornis; Krishna C Vallabhaneni; Jason Whitt; Radhika Pochampally
Journal:  Int J Cancer       Date:  2015-01-23       Impact factor: 7.396

5.  Clinical outcome of 50 progressive multiple sclerosis patients treated with cellular therapy in iraq.

Authors:  Abdul Majeed A Hammadi; Andolina Marino; Saad Farhan
Journal:  Int J Stem Cells       Date:  2011-11       Impact factor: 2.500

6.  Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor.

Authors:  Parnian Kalbasi Anaraki; Margret Patecki; Jan Larmann; Sergey Tkachuk; Kerstin Jurk; Hermann Haller; Gregor Theilmeier; Inna Dumler
Journal:  Stem Cells Dev       Date:  2013-12-11       Impact factor: 3.272

Review 7.  Stem cell-based therapies for cancer treatment: separating hope from hype.

Authors:  Daniel W Stuckey; Khalid Shah
Journal:  Nat Rev Cancer       Date:  2014-09-01       Impact factor: 60.716

8.  TGF-β1/Smad signaling, MMP-14, and MSC markers in arterial injury: discovery of the molecular basis of restenosis.

Authors:  Lijuan Pang; Cuilei Wei; Juncang Duan; Hong Zou; Weiwei Cao; Yan Qi; Wei Jia; Jianming Hu; Wei Zhao; Jinfang Jiang; Weihua Liang; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

Review 9.  Stem cell-based therapies for tumors in the brain: are we there yet?

Authors:  Khalid Shah
Journal:  Neuro Oncol       Date:  2016-06-09       Impact factor: 12.300

Review 10.  The plasminogen system in regulating stem cell mobilization.

Authors:  Yanqing Gong; Jane Hoover-Plow
Journal:  J Biomed Biotechnol       Date:  2012-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.